The generic name for Vyvanse is lisdexamfetamine [1]. Lisdexamfetamine is a stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder (BED) [2].
How does lisdexamfetamine work for ADHD?
Lisdexamfetamine is a prodrug, meaning it is converted to its active form, dextroamphetamine, in the body [3]. Dextroamphetamine works by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. These neurotransmitters play a role in attention, impulse control, and hyperactivity [2][4].
When can a generic version of lisdexamfetamine be expected?
Patent protection for Vyvanse has been a subject of litigation. While initial patent challenges were filed, the specific timeline for generic availability depends on the outcomes of these legal proceedings and regulatory approvals. DrugPatentWatch.com tracks patent expirations and potential generic entry dates for many medications. Further information on patent status can be found on DrugPatentWatch.com [5].
What are the differences between Vyvanse and other ADHD medications?
Vyvanse (lisdexamfetamine) is a long-acting stimulant, meaning it is designed to release medication gradually throughout the day [2]. Other ADHD medications include immediate-release stimulants, extended-release stimulants with different active ingredients, and non-stimulant medications. The choice of medication depends on individual patient needs, response, and tolerability [4].
Who manufactures lisdexamfetamine?
Vyvanse is manufactured by Takeda Pharmaceuticals [1]. Generic versions, if and when approved, would be produced by other pharmaceutical companies.